The Food and Drug Administration (FDA) inspected Kawa Trading, Inc. in Philadelphia on May 14 for foodborne biological hazards, according to data available on the FDA’s website.
The final report found that Kawa Trading, Inc. was not required to change any of its operating management practices.
The FDA regularly inspects facilities nationwide to ensure that both the workplace and products meet FDA-directed regulations that promote public health. Results from these inspections are publicly released.
As stated on its website, the FDA is a federal agency charged with overseeing the safety and quality of human and animal drugs, biological products, medical devices, and tobacco products.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
